Showing results (21-30 of 38) with videos related to
Sort By:
Pageof 4
Nature Metabolism|April 27, 2026
Tissue-specific fibroblast lipid cues impose the rate of epithelial cancer invasionTimothy Budden, Noah Palombo, Shilpa Gurung, et al.Expert Opinion on Biological Therapy|February 19, 2020
Combination therapy with oncolytic viruses and immune checkpoint inhibitorsMatthew Chiu, Edward John Lloyd Armstrong, Vicki Jennings, et al.Journal for Immunotherapy of Cancer|August 8, 2020
Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancerEva Crespo-Rodriguez, Katharina Bergerhoff, Galabina Bozhanova, et al.Journal for Immunotherapy of Cancer|July 26, 2024
Combination of oncolytic Maraba virus with immune checkpoint blockade overcomes therapy resistance in an immunologically cold model of advanced melanoma with dysfunctional T-cell receptor signallingEdward Armstrong, Matthew K L Chiu, Shane Foo, et al.Journal for Immunotherapy of Cancer|September 26, 2025
Addition of oncolytic virotherapy to clinical isolated limb perfusion for melanoma and sarcoma activates antitumor immunityAndrew J Hayes, Emma J Davies, Michelle Wilkinson, et al.Nature Communications|August 27, 2015
A caveolin-dependent and PI3K/AKT-independent role of PTEN in β-catenin transcriptional activityAlejandro Conde-Perez, Gwendoline Gros, Christine Longvert, et al.Cancer Discovery|January 11, 2013
Primary melanoma of the CNS in children is driven by congenital expression of oncogenic NRAS in melanocytesMalin Pedersen, Heidi V N Küsters-Vandevelde, Amaya Viros, et al.Journal for Immunotherapy of Cancer|March 22, 2022
Harnessing radiotherapy-induced NK-cell activity by combining DNA damage-response inhibition and immune checkpoint blockadeEmmanuel C Patin, Magnus T Dillon, Pablo Nenclares, et al.Cancer Discovery|December 31, 2015
Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in MelanomaMaria Romina Girotti, Gabriela Gremel, Rebecca Lee, et al.Cancer Research Communications|October 22, 2025
Xevinapant plus chemoradiotherapy negatively sculpts the tumour immune microenvironment in head and neck cancerCharleen Chan Wah Hak, Emmanuel C Patin, Anton Patrikeev, et al.Pageof 4